Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer

NCT00193128 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: Capecitabine
RADIATION: Radiation therapy

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]